Responsiveness of the DLQI and the Colombian Validated Version of the Skindex-29 in Scarring and Non-Scarring Alopecia

    November 2024 in “ Skin Appendage Disorders ”
    Joaquín Rodríguez Sánchez, Cristian Mora, G.A. Mancilla, Gloria Sanclemente
    Image of study
    TLDR Telogen effluvium most affects quality of life in alopecia patients.
    This study assessed the quality of life (QoL) impact of various types of alopecia using the Skindex-29 and Dermatology Life Quality Index (DLQI) in a Colombian cohort. Conducted in Medellín with a longitudinal design, it included two measurements over time. The study found that telogen effluvium (TE) had the greatest QoL impact, followed by alopecia areata (AA), dissecting cellulitis, and lichen planus pilaris. The Colombian versions of Skindex-29 and DLQI demonstrated moderate responsiveness in evaluating QoL changes in patients with both scarring and non-scarring alopecia before and after treatment. Women comprised 51% of the participants, with androgenic alopecia being the most common type at 52%.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 404 results

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 2 months ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

      community any news about DUPA (Diffuse unpatterned alopecia)?

      in Research/Science  11 upvotes 1 year ago
      The conversation discusses diffuse unpatterned alopecia (DUPA) and its possible causes, including sensitivity to DHT, not being androgenic alopecia, being diffuse alopecia areata, or hormonal issues. Treatments mentioned include topical melatonin, Clobetasol Propionate for alopecia areata, and the lack of results from using finasteride, dutasteride, and minoxidil.

      community No idea what's causing my hair thinning

      in Chat  2 upvotes 1 month ago
      The user is experiencing diffuse hair thinning despite using finasteride and oral minoxidil, with no hairline recession or bald spots. Suggestions include checking for telogen effluvium, considering a JAK inhibitor for potential autoimmune issues, and conducting further tests to rule out other causes.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  40 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Similar Research

    5 / 1000+ results